BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Entasis Therapeutics

Entasis Therapeutics logo

Founded
2015
Geography
United States of America based
Funding
$128.200 M

Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Entasis’ anti-infective discovery platform has produced a pipeline of meaningfully differentiated programs which target serious bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), and zoliflodacin (targeting Neisseria gonorrhoeae).


Posts Mentioning This Company

R&D Platform

-


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet